Clinical Research Directory

Inclusion Criteria: * Age \> 18 years old * Has self-reported sleep disturbance * Insomnia Severity Index (ISI) score of \> 15, with score on question on difficulty falling asleep \> 2 ("moderate") at screening * Interested in understanding more about their sleep and choose to use the probiotic product * Willing to do a 1-week washout out of any OTC or other products for sleep and/or (e.g. melatonin, anticholinergics, valerian root etc.) prior to randomization and refrain from use for the duration of the study * Willing to do a 4-week washout from any systemic antibiotic, prebiotic, probiotic and postbiotic use prior to randomization * If taking prescription medications for sleep and/or anxiety (e.g. Benzodiazepines, zolpidem, zaleplon, SSRIs, Buspirone, Tricyclics, MAOIs), or other class of medication for sleep, must be on a "stable dose" for at least 4 weeks prior to randomization. "Stable dose" is defined as no changes in dosage or frequency of the specified medications for at least 4 weeks prior to randomization and throughout the study period. * If using any cannabis-containing products, must be on a stable dose for at least 4 weeks prior to randomization and consume \< 10 mg/day of THC * If regularly consuming alcohol, must be willing to stay on a stable amount throughout the study period and to log alcohol consumption. * In good general health at the time of screening (Investigator discretion). * Able to read and understand English. * Able to read, understand, and provide informed consent. * Able to use a personal smartphone device and download Chloe by People Science. * Able to receive shipment of the product at an address within the United States. * Is willing to wear, sync daily, and charge twice weekly a provisioned health tracking wearable device (Oura ring) everyday (up to 7 weeks) during sleep. If the participant already has an Oura ring, they can use their own device and account. * Able to complete study assessments over the course of up to 7 weeks. Exclusion Criteria: * Do not have a smartphone and/or internet access. * Concomitant Therapies: * Participants taking prescription medication for sleep and/or anxiety (e.g. Benzodiazepines, zolpidem, zaleplon, SSRIs, Buspirone, Tricyclics, MAOIs) not on a stable dose for at least 4 weeks * Participants receiving Cognitive Behavioral Therapy for Insomnia (CBTi) * Participants receiving any investigational therapies or treatments within 30 days prior to randomization. * Participants taking any other prescription medications that impact systemic GABA levels (e.g., GABA supplements, barbiturates, gabapentin, pregabalin, valproate, tiagabine, vigabatrin, baclofen) * Participants currently taking or have taken probiotics, prebiotics or postbiotics within the past 4 weeks prior to randomization. * Current antibiotic use or use within 4 weeks prior to randomization. * Other Illnesses or Conditions: Participants who have the following conditions or comorbidities are excluded: * Confirmed diagnoses of the following sleep disorders: Narcolepsy, Restless Leg Syndrome, Circadian Rhythm Disorders * Confirmed diagnosis of Sleep Apnea that is untreated or not well controlled * Known diagnosis of Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) or Irritable Bowel Syndrome * Current or prior history of psychotic disorder * Confirmed diagnosis of major depressive disorder or bipolar disorder * Diagnosed with Alcohol or Substance Abuse Disorder * Currently pregnant, planning to become pregnant in the next 1 month, or breastfeeding * Presence of any infection or illness that causes chronic night-waking or impairs ability to retain urine overnight (e.g., chronic pain, uncontrolled benign prostatic hyperplasia, prostatitis, urinary tract infection, catheterization, etc.). * Have a significant illness, disease or condition which, in the opinion of the principal investigator, may impact their ability to participate in the trial or impact the trial outcomes. * Known hypersensitivity or previous allergic reaction to microcrystalline cellulose (MCC). * Presence of another environmental factor that severely impacts sleep quality (e.g., a new baby, pet or other loved one that wakes frequently or needs frequent care or feeding throughout the night) * Work in an environment requiring shift work (e.g., rotating shifts, night shifts, or irregular hours). * Have any known and planned international travel during the study period. * Are unlikely for any reason to be able to comply with the trial or considered unsuited for participation in the study by the Principal Investigator.